A REVIEW OF THE PRESCRIPTION PRACTICE FOR DUAL ANTI-PLATELET AGENTS IN NSTE-ACS

anish George, Joseph John

Abstract


Aim: To review the practice of prescribing dual anti-platelet agents for patients with NSTE-ACS (Non ST Elevation Acute Coronary Syndrome).

 

Methodology: The audit was done in 2 phases, a retrospective phase and a prospective phase, involving 329 patients.

 

Findings: The study revealed that 87.4% (277 out of 317) of patients received loading dose of aspirin, while 91.3 % (251 out of 275) received Clopidogrel. It also showed that 13% (36 out of 279) of patients who were eligible for dual anti-platelet agents did not receive them. The retrospective part of the audit showed that only 37 out of 53 patients were on dual anti-platelets at end of the recommended 12 months.

 

Conclusion: The audit shows that greater awareness is needed, with regard to the role of dual anti-platelet therapy for NSTE-ACS, in the acute medical and community medical practice setting.

 

Keywords: NSTE-ACS, NICE guidelines, audit, aspirin, clopidogrel


Full Text:

PDF

Refbacks

  • There are currently no refbacks.